Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose

Biochemical and Biophysical Research Communications

Volumn 409, Issue 1, 2011, Pages 131-136

  Ju, Huanyu ^a   Wei, Na ^a   Wang, Qian ^a   Wang, Chunyuan ^a   Jing, Zhiqiang ^a   Guo, Lu ^a   Liu, Dapeng ^a   Gao, Mingchun ^a   Ma, Bo ^a   Wang, Junwei ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Baculovirus; Capsid protein; Goose parvovirus; Virus like particles

Indexed keywords

RECOMBINANT PROTEIN; RECOMBINANT VIRUS PROTEIN 1; RECOMBINANT VIRUS PROTEIN 2; RECOMBINANT VIRUS PROTEIN 3; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DERZSY DISEASE; DUCK; ELECTRON MICROSCOPY; EMBRYO; FIBROBLAST; GENE AMPLIFICATION; GOOSE; GOOSE PARVOVIRUS; IMMUNOGENICITY; IMMUNOREACTIVITY; IN VITRO STUDY; INSECT CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; VACCINATION; VIRION; VIRUS ASSEMBLY; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

ANIMALS; BACULOVIRIDAE; CAPSID PROTEINS; GEESE; INSECTS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; POULTRY DISEASES; RECOMBINANT PROTEINS; VIRAL VACCINES; VIRION; VIRUS ASSEMBLY;

ANSER; GOOSE PARVOVIRUS; HEXAPODA; MIRIDAE; SSDNA VIRUSES;

EID: 79956200555     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.129     Document Type: Article

References (43)

1. R.E. Gough, Goose parvovirus infection, in: B.W. Calnek, H. John Barnes, C.W. Beard, W.M. Reid, H. Yoder (Eds.), Disease of Poultry, Iowa State University Press, Ames.Iowa, pp.684-690.
2. J. Kisary, Derzsy's disease of geese, in: J.B. Mc Ferran, M.S. Mc Nulty (Eds.), Virus Infections of Vertebrates,vol. 4, Elsevier, Amsterdam, pp.157-162.
3. C.M. Fauquet, M.A. Mayo, J. Maniloff, VIIIth Report of the ICTV, Virus Taxonomy, Elsevier/Academic Press, London, England, 2004.
4. Zadori Z., Erdei J., Nagy J., Kisary J. Characteristics of the genome of goose parvovirus. Avian Pathol. 1994, 23:359-364.
5. Zadori Z., Stefancsik R., Rauch T., Kisary J. Analysis of the complete nucleotide sequences of goose and muscovy duck parvoviruses indicates common ancestral origin with adeno-associated virus 2. Virology 1995, 212:562-573.
6. Maranga L., Cruz P.E., Aunins J.G., Carrondo M.J. Production of core and virus-like particles with baculovirus infected insect cells. Adv. Biochem. Eng. Biotechnol. 2002, 74:183-206.
7. Sabara M., Parker M., Aha P., Cosco C., et al. Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins. J. Virol. 1991, 65:6994-6997.
8. Urakawa T., Ferguson M., Minor P.D., et al. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J. Gen. Virol. 1989, 70(Pt 6):1453-1463.
9. French T.J., Marshall J.J., Roy P. Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J. Virol. 1990, 64:5695-5700.
10. Plana-Duran J., Bastons M., Rodriguez M.J., et al. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch. Virol. 1996, 141:1423-1436.
11. Rose R.C., Bonnez W., Reichman R.C., Garcea R.L. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J. Virol. 1993, 67:1936-1944.
12. Thomsen D.R., Roof L.L., Homa F.L. Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J. Virol. 1994, 68:2442-2457.
13. Hoque M., Shimizu N., Ishizu K., et al. Chimeric virus-like particle formation of adeno-associated virus. Biochem. Biophys. Res. Commun. 1999, 266:371-376.
14. Wu H., Rossmann M.G. The canine parvovirus empty capsid structure. J. Mol. Biol. 1993, 233:231-244.
15. Brown C.S., Van Lent J.W., Vlak J.M., Spaan W.J. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J. Virol. 1991, 65:2702-2706.
16. Kajigaya S., Fujii H., Field A., et al. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA 1991, 88:4646-4650.
17. Rueda P., Fominaya J., Langeveld J.P., et al. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 2000, 19:726-734.
18. Lopez D.T.J., Cortes E., Martinez C., et al. Recombinant vaccine for canine parvovirus in dogs. J. Virol. 1992, 66:2748-2753.
19. Ruffing M., Zentgraf H., Kleinschmidt J.A. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol. 1992, 66:6922-6930.
20. Le Gall-Recule G., Jestin V., Chagnaud P., et al. Expression of muscovy duck parvovirus capsid proteins (VP2 and VP3) in a baculovirus expression system and demonstration of immunity induced by the recombinant proteins. J. Gen. Virol. 1996, 77(Pt 9):2159-2163.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Harris J.R., Bhella D., Adrian M. Developments in negative staining for transmission electron microscopy. Microsc. Anal. 2006, 20:17-21.
23. Takehara K., Nakata T., Takizawa K., et al. Expression of goose parvovirus VP1 capsid protein by a baculovirus expression system and establishment of fluorescent antibody test to diagnose goose parvovirus infection. Arch. Virol. 1999, 144:1639-1645.
24. Christensen J., Alexandersen S., Bloch B., et al. Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink. J. Gen. Virol. 1994, 75(Pt 1):149-155.
25. Christensen J., Storgaard T., Bloch B., et al. Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system. J. Virol. 1993, 67:229-238.
26. Martinez C., Dalsgaard K., Lopez D.T.J., et al. Production of porcine parvovirus empty capsids with high immunogenic activity. Vaccine 1992, 10:684-690.
27. Saliki J.T., Mizak B., Flore H.P., et al. Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J. Gen. Virol. 1992, 73(Pt 2):369-374.
28. Le Gall-Recule G., Jestin V. Biochemical and genomic characterization of muscovy duck parvovirus. Arch. Virol. 1994, 139:121-131.
29. Gilbert L., Toivola J., Lehtomaki E., et al. Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells. Biochem. Biophys. Res. Commun. 2004, 313:878-887.
30. Warrington K.J., Gorbatyuk O.S., Harrison J.K., et al. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J. Virol. 2004, 78:6595-6609.
31. Andre F.E., Safary A. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. J. Postgrad. Med. 1987, 63(Suppl 2):169-177.
32. Montenarh M., Henning R. Disaggregation and reconstitution of oligomeric complexes of simian virus 40 large T-antigen. J. Gen. Virol. 1983, 64(Pt 1):241-246.
33. Bertolotti-Ciarlet A., Ciarlet M., Crawford S.E., et al. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine 2003, 21:3885-3900.
34. Brady J.N., Winston V.D., Consigli R.A. Dissociation of polyoma virus by the chelation of calcium ions found associated with purified virions. J. Virol. 1977, 23:717-724.
35. Swenson D.L., Warfield K.L., Negley D.L., Schmaljohn A., Aman M.J., Bavari S. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 2005, 23:3033-3042.
36. McAleer W.J., Buynak E.B., Maigetter R.Z., et al. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180.
37. Harper D.M., Franco E.L., Wheeler C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367:1247-1255.
38. Mao C., Koutsky L.A., Ault K.A., et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet. Gynecol. 2006, 107:18-27.
39. Villa L.L., Costa R.L., Petta C.A., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005, 6:271-278.
40. Latham T., Galarza J.M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 2001, 75:6154-6165.
41. Pushko P., Tumpey T.M., Bu F., et al. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005, 23:5751-5759.
42. Vieira H.L., Estevao C., Roldao A., et al. Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production. J. Biotechnol. 2005, 120:72-82.
43. Warfield K.L., Swenson D.L., Negley D.L., et al. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine 2004, 22:3495-3502.